Purchase Order 75N95D20P00029

<p>The National Institute on Aging awarded a purchase order to Psomagen Inc. on August 20, 2024, for whole genome sequencing services with a ceiling value of $7,499,725 and an ultimate completion date of September 24, 2025. The order carries a Total Small Business set-aside designation. Work is performed in Rockville, Maryland. The purchase order covers whole genome sequencing on 500 samples supporting neurodegenerative disease research, procured on a firm fixed-price basis.</p>

<p>The National Institutes of Health National Institute on Aging awarded a $600,000 Purchase Order to Psomagen Inc. of Potomac, Maryland to provide Whole Genome Sequencing Services for 1,000 samples. The contract has a period of performance from September 22, 2022 through September 21, 2023 and utilizes a Firm Fixed Price pricing structure. No subcontractors were identified.</p>

This firm-fixed price purchase order for $600,000 was awarded by the National Institute on Aging, a component of the National Institutes of Health within the Department of Health and Human Services, to Psomagen, Inc. for whole genome sequencing services. Under the terms of the contract, Psomagen will sequence 1,000 human samples to 30x coverage using Illumina sequencing technologies and deliver raw sequencing data files within 4-6 weeks. The work will be performed in Potomac, Maryland over a one...

<p>The National Institutes of Health National Institute on Aging awarded a $288,900.00 purchase order to Psomagen Inc., a subsidiary of Macrogen, Inc., to provide single cell multiome sequencing services from July 3, 2023 through July 2, 2024. The firm fixed price contract will support Psomagen in conducting single cell multiome sequencing at its facility located in Potomac, Maryland to assist the National Institutes of Health National Institute on Aging in advancing biomedical research.</p>

<p>The National Institute of Nursing Research awarded a purchase order to Psomagen Inc. valued at $24,970 on September 8, 2020. The order carries no set-aside designation. Work is performed at Bethesda, Maryland. The purchase order covers genomic sequencing and bioinformatics services, with a firm fixed price structure and an ultimate completion date of February 8, 2021.</p>

This is a $3,849,800.00 firm fixed-price purchase order contract awarded to Psomagen Inc., a small business, by the National Institute on Aging (NIA), a component of the National Institutes of Health (NIH). The contract is for neurodegenerative disease research, including whole genome sequencing services, with a completion date of September 14, 2024. Psomagen Inc. is a subsidiary of Macrogen, Inc. and is a provider of genomic sequencing, bioinformatics, and related services to federal government...

This is a $64,800 firm-fixed price purchase order awarded by the National Institute on Aging (NIA), part of the National Institutes of Health (NIH), to Psomagen Inc. for RNA sequencing services to support neurodegenerative disease research. The contract has a period of performance from August 1, 2024 to December 31, 2024. Psomagen will provide total RNA sequencing, including library preparation, sequencing, and data delivery, for 324 human samples. This is a non-competitive award, as Psomagen...

The U.S. civilian federal government awarded a $3,500 firm fixed-price purchase order for DNA sequencing services to Psomagen Inc., a genomics and molecular biology services company based in Rockville, Maryland and subsidiary of Macrogen, Inc. The contract, awarded on April 10, 2018, with performance to be completed by the same date, represents a ratifying order with no small business set-aside designation. Work is to be performed in Potomac, Maryland. Psomagen specializes in advanced genomic...

The National Heart, Lung and Blood Institute awarded a purchase order to Psomagen Inc. for $33,223.00 on February 28, 2017, for DNA sequencing services. Ultimate completion was February 27, 2018. Work is performed at North Bethesda, Maryland. The order carries firm fixed price terms and no small business set-aside. Psomagen is a for-profit genomics and molecular biology services company and a subsidiary of Macrogen, Inc., operating CLIA-certified and CAP-accredited facilities that provide...

The National Institute of Allergy and Infectious Diseases awarded a $17,810 firm fixed price purchase order to Psomagen Inc. on September 13, 2021, with an ultimate completion date of August 4, 2022. This contract action was undertaken to administratively de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a), in preparation for the September 30, 2026 closing of the period of availability for these fiscal year funds. The work was performed in...